KEY DEADLINES
Abstract Submission Deadline: 24 February 2023
Registration Open: Late January 2023
Early Bird Registration Deadline: 14 May 2023
Accommodation Deadline: 9 June 2023
KEY DEADLINES
Abstract Submission Deadline: 24 February 2023
Registration Open: Late January 2023
Early Bird Registration Deadline: 14 May 2023
Accommodation Deadline: 9 June 2023
For over three years, the world has been preoccupied with the emergence of the SARSCoV-2 virus and the resulting COVID-19 pandemic, including the rapid development of treatments and vaccines. The pandemic has challenged the social and political structures of all countries and has had an impact on the lives of people at a global level.
Meanwhile our scientists, healthcare providers, public health experts and academics across multiple disciplines have been called upon to help understand and make sense of what is going on around us – social distancing, face masks, predictive modelling, virus origin theories and conspiracies, variants and vaccines – our language and behaviours have had to change to meet a crisis on a scale that few have witnessed.
To respond to this evolving challenge, ASHM, with support of key stakeholders made the decision to run a one-day COVID-19 in September 2021 conference, virtually. In 2022, the conference was held for a second time as a hybrid event in Sydney on 21-22 July. This event was convened by Professor Sharon Lewin, AO, Director of the Peter Doherty Institute and Professor Allen Cheng, Director of the Infection Prevention and Healthcare Epidemiology unit at Alfred Health. The Program chair was Associate Professor Edwina Wright, AM, of the Alfred Hospital and Monash University in Melbourne.
Given the success, interest and ongoing challenges of COVID-19 (including increasing options in treatment and management of disease) ASHM and the committee is moving forward with a third conference which will be in person, taking place 27 – 28 July 2023. The conference will once again invite leading scientists and clinicians to develop the program and be invited to speak on the everevolving COVID-19 and present new and emerging data especially in management of COVID-19.